Conference News
October 14, 2024
Euretina 2024: Voretigene Neparvovec-rzyl Therapy Long-Term Functional and Anatomical Outcomes
Conexiant
October 14, 2024
p300 KAT Inhibitors Offer Potential Approach for Inflammatory and Autoimmune Conditions
Conexiant
October 07, 2024
Euretina 2024: Faricimab Shows Greater Hard Exudate Reduction Compared with Aflibercept
Conexiant
October 07, 2024
Euretina 2024: Aflibercept Showed Efficacy and Safety vs Laser Therapy in Retinopathy of Prematurity
Conexiant
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Advertisement
Recommendations
Advertisement